주식회사밸리
주식회사밸리's KOBDi Score is 45.65 as of Sep 2026, down 2.74 points since Apr 2025; it rose in 5 and fell in 3 of the 12 monthly updates. As of Sep 2026 it is ahead of about 10% of companies in its industry, against 10% in Aug 2026 and the lower 10% in Apr 2025. Its strongest position was 10% (Sep 2026) and its weakest the lower 10% (Jul 2025).
A year earlier, in Aug 2025, its score was 43.19 and it was in the lower 10% of its industry.
| Sep 2026 | 45.65 | ahead of 10% |
| Aug 2026 | 45.26 | ahead of 10% |
| Jul 2026 | 45.26 | ahead of 10% |
| Jun 2026 | 45.26 | ahead of 10% |
| May 2026 | 45.26 | ahead of 10% |
| Apr 2026 | 43.40 | lower 10% |
| Mar 2026 | 43.40 | lower 10% |
| Feb 2026 | 46.83 | ahead of 10% |
| Dec 2025 | 46.67 | ahead of 10% |
| Aug 2025 | 43.19 | lower 10% |
| Jul 2025 | 41.03 | lower 10% |
| May 2025 | 43.27 | lower 10% |
| Apr 2025 | 48.39 | lower 10% |
Where is 주식회사밸리 located?
주식회사밸리 is registered at 대구 수성구 파동로32길, South Korea (postal code 42230).
What industry is 주식회사밸리 in?
주식회사밸리 belongs to Manufacturing › Pharmaceuticals & Biologics › Finished pharmaceutical manufacturing.
How many employees does 주식회사밸리 have?
주식회사밸리 has 5–9 employees.
What is 주식회사밸리's KOBDi Score?
45.65 as of September 2026, ahead of about 10% of companies in its industry.
Who are 주식회사밸리's competitors?
Similar companies include GENENMED, Samgong C&P and Emb Pharmaceutical.

